Resources

Guidance for completing an import permit application for narcotic and psychotropic substances.

Guidance for completing applications for a licence and permit to import substances under the Special Access Scheme (SAS) and Authorised Prescriber (AP) only.

Guidance for completing an export permit application for narcotic, psychotropic and precursor substances.

Guidance for completing an import permit application for precursor substances.

Guidance for completing the triplicate document to clear imported kava with Australian Border Force (ABF).

Guidance for completing an import or export licence application for narcotic, psychotropic and precursor substances.

Guidance on holding a precursor export licence and submitting a Pre-Export Notification (PEN) for precursor substances.

Information for all medicinal cannabis permit holders (cultivators, producers and manufacturers) to complete the quarterly cannabis reporting template.

The ODC Cannabis Reporting Template is for use by all medicinal cannabis permit holders under the Narcotic Drugs Act 1967.

The Office of Drug Control Business Plan for 2022-23 is now available.

Application form for permission to import kava for medical and scientific purposes or food use.

Application form for permission to import narcotic and psychotropic substances to Australia.

View our sample template for the medicinal cannabis permit for manufacture.

View our sample template for the medicinal cannabis permit for cultivation & production.

View our sample template for the new single Medicinal cannabis licence.

Reporting template for people who import kava for food use.

Application form for a medicinal cannabis permit – cultivation and production.

Information for applicants who intend to apply for a medicinal cannabis permit for medicinal or scientific purposes – cultivation and production activities.

Information for applicants who intend to apply for a medicinal cannabis permit for medicinal or scientific purposes – manufacture activities.

The Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis) ensures that medicinal cannabis products meet quality standards, whether or not those products are imported or manufactured domestically. 

The Office of Drug Control Business Plan for January-June 2022 is now available.

The Narcotic Drugs Act 1967 gives effect to some of Australia’s obligations under the Single Convention on Narcotic Drugs, 1961.

The Narcotic Drugs (Licence Charges) Regulation 2016 puts into place the regulatory licence charges for licences relating to medicinal cannabis, commercial cannabis research and non-commercial cannabis research as provided for under the Narcotic Drugs (Licence Charges) Act 2016.

Information on how the Office of Drug Control implements cost recovery for regulatory activities.

Information on how the Office of Drug Control implements cost recovery for regulatory activities.